Destiny Pharma Ltd. - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Destiny Pharma Ltd. - Product Pipeline Review - 2014" provides data on the Destiny Pharma Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Destiny Pharma Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Destiny Pharma Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Destiny Pharma Ltd. - Brief Destiny Pharma Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Destiny Pharma Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Destiny Pharma Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Destiny Pharma Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Destiny Pharma Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Destiny Pharma Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Destiny Pharma Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Destiny Pharma Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Destiny Pharma Ltd. and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Destiny Pharma Ltd. Snapshot 4
Destiny Pharma Ltd. Overview 4
Key Information 4
Key Facts 4
Destiny Pharma Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
Destiny Pharma Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Destiny Pharma Ltd. - Pipeline Products Glance 9
Destiny Pharma Ltd. - Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Destiny Pharma Ltd. - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Destiny Pharma Ltd. - Drug Profiles 12
XF-73 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
DPD-207 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
XF-70 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Bio-Defense Applications XF Drugs 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Destiny Pharma Ltd. - Pipeline Analysis 16
Destiny Pharma Ltd. - Pipeline Products by Therapeutic Class 16
Destiny Pharma Ltd. - Pipeline Products by Target 17
Destiny Pharma Ltd. - Pipeline Products by Route of Administration 18
Destiny Pharma Ltd. - Pipeline Products by Molecule Type 19
Destiny Pharma Ltd. - Pipeline Products by Mechanism of Action 20
Destiny Pharma Ltd. - Recent Pipeline Updates 21
Destiny Pharma Ltd. - Dormant Projects 22
Destiny Pharma Ltd. - Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
Coverage 24
Secondary Research 24
Primary Research 24
Expert Panel Validation 24
Contact Us 25
Disclaimer 25

List of Tables
Destiny Pharma Ltd., Key Information 4
Destiny Pharma Ltd., Key Facts 4
Destiny Pharma Ltd. - Pipeline by Indication, 2014 6
Destiny Pharma Ltd. - Pipeline by Stage of Development, 2014 7
Destiny Pharma Ltd. - Monotherapy Products in Pipeline, 2014 8
Destiny Pharma Ltd. - Phase II, 2014 9
Destiny Pharma Ltd. - Preclinical, 2014 10
Destiny Pharma Ltd. - Discovery, 2014 11
Destiny Pharma Ltd. - Pipeline by Therapeutic Class, 2014 16
Destiny Pharma Ltd. - Pipeline by Target, 2014 17
Destiny Pharma Ltd. - Pipeline by Route of Administration, 2014 18
Destiny Pharma Ltd. - Pipeline by Molecule Type, 2014 19
Destiny Pharma Ltd. - Pipeline Products by Mechanism of Action, 2014 20
Destiny Pharma Ltd. - Recent Pipeline Updates, 2014 21
Destiny Pharma Ltd. - Dormant Developmental Projects,2014 22